Why the study?
Optimal pharmacological treatment of heart failure remains an ongoing challenge with lagging uptake, driven by lack of knowledge and discomfort with safe initiation and monitoring of guideline-directed medical therapy.
Does a Heart Failure Society of America-Developed Educational Module improve clinician comfort with initiation and optimization of Guideline-Directed Medical Therapy?
Does a Heart Failure Society of America-Developed Educational Module improve clinician comfort with initiation and optimization of Guideline-Directed Medical Therapy?
An educational module developed by the Heart Failure Society of America aims to address implementation gaps by improving clinician comfort with GDMT initiation and optimization.
Offers clinicians a tool to boost GDMT uptake; extends HFSA guidelines into actionable education.
Despite the growing burden of heart failure (HF), with more than 6.7 million American adults today carrying this diagnosis,1 optimal pharmacological treatment is an ongoing challenge, and global registries show lagging uptake.2 These implementation gaps contribute to significant morbidity; HF accounts for 6.5 million hospital days annually.3 Lack of knowledge of indications, comanagement with other providers, and discomfort with safe initiation and monitoring practices are known contributors to missed opportunities for optimization of Guide-Directed Medical Therapy (GDMT).
No takes yet. Share an insight, caveat, or question.
Albert et al. (2025) studied Heart failure. Heart Failure Society of America-Developed Educational Module was evaluated on Clinician comfort with initiation and optimization of guideline-directed medical therapy. A Heart Failure Society of America-developed educational module improves clinician comfort with initiation and optimization of guideline-directed medical therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: